
Addiction of primary cutaneous γδ T cell lymphomas to JAK/STAT signaling.
Original investigation; PMID 40231467.
View publication →
Selected peer-reviewed publications from the Choi Lab and collaborators.
The featured carousel above stays unchanged. Below, the rest of the publication record is grouped into a cleaner, easier-to-scan directory.
Use the category links to jump through the publication record without making the page feel crowded. The first section is open by default; the others expand as needed.
83 non-featured entries are organized by publication type.
J Clin Invest. 2025 Nov 3;135(21):e190853. doi: 10.1172/JCI190853.
View publication →Blood Adv. 2025 Apr 22;9(8):1786-1790. Co-corresponding author.
View publication →Nature Communications. 2020 Apr;11:1806. Corresponding author; named an Editor's weekly highlight.
View publication →J Invest Dermatol. 2018 Nov;138(11):2365-2376. Corresponding author.
View publication →Cell Immunology. 2017 Sep;319:28-34. Co-corresponding author.
View publication →Blood. 2017 Sep 21;130(12):1430-1440. Corresponding author; featured in Inside Blood commentary.
View publication →J Invest Dermatol. 2017 Apr;137(4):951-954. Senior author.
View publication →Blood. 2016 Feb;127(7):948-951. Corresponding author.
View publication →Oncotarget. 2016 Jan;7(3):3403-3415. Co-corresponding author; profiled by F1000.
View publication →Nat Genet. 2015 Sep;47(9):1011-1019.
View publication →Pigment Cell Melanoma Res. 2014 Mar;27(2):253-262. Co-corresponding author.
View publication →J Virol. 2005 Sep;79(17):11194-11204.
View publication →J Virol. 2005 Jan;79(1):264-276.
View publication →J Am Acad Dermatol. 2026 Feb;94(2):548-556.
View publication →Leuk Lymphoma. 2025 Jul;66(7):1354-1357.
View publication →Immunity. 2024 Nov 12;57(11):2634-2650.e5.
View publication →J Clin Oncol. 2024 Sep 10;42(26):3151-3161.
View publication →J Immunol. 2024 Jun 15;212(12):1867-1876.
View publication →J Cutan Pathol. 2024 Jun;51(6):459-467.
View publication →Clinical Cancer Research. 2024 Jun 3;30(11):2514-2530.
View publication →JAMA Dermatol. 2024 Feb 1;160(2):172-178.
View publication →Science Immunology. 2024 Jan 26;9(92).
View publication →Arch Dermatol Res. 2023 Mar;315(2):275-278.
View publication →J Am Acad Dermatol. 2023 Feb;88(2):329-337.
View publication →J Invest Dermatol. 2022 Dec;142(12):3253-3261.
View publication →Front Immunol. 2022 Nov 11;13:1022093.
View publication →J Am Acad Dermatol. 2022 Nov;87(5):1140-1141.
View publication →J Immunother Cancer. 2022 Sep;10(9):e005328.
View publication →JAMA Dermatol. 2022 Sep 1;158(9):1073-1076.
View publication →J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1552-1563.
View publication →Cell Reports Medicine. 2022 Aug 16;3(8):100715.
View publication →J Am Acad Dermatol. 2022 May;86(5):1120-1123.
View publication →Science Immunology. 2022 Apr 15;7(70).
View publication →Eur J Dermatol. 2021 Dec 1;31(6):841-843.
View publication →J Invest Dermatol. 2022 Feb;142(2):493-496.
View publication →J Immunol. 2021 Aug;207(3):765-770.
View publication →iScience. 2020 Sep;23(10):101582.
View publication →J Am Acad Dermatol. 2020 Jul;83(1):197-199.
View publication →Biomater Sci. 2019 Jan 2;7(2):657-668.
View publication →JAMA Dermatol. 2018 Jul;154(7):828-831.
View publication →J Am Acad Dermatol. 2018 Jun;78(6):1068-1076.
View publication →Clin Cancer Res. 2018 Feb 15;24(4):963-971.
View publication →J Invest Dermatol. 2018 Feb;138(2):384-393.
View publication →J Am Acad Dermatol. 2017 Sep;77(3):489-496.
View publication →J Invest Dermatol. 2017 Mar;137(3):751-753.
View publication →Neuro Oncol. 2016 Oct;18(10):1402-1412.
View publication →J Invest Dermatol. 2016 Sep;136(9):1858-1865.
View publication →Cell Reports. 2016 Jun 7;15(10):2170-2184.
View publication →J Am Acad Dermatol. 2016 May;74(5):870-877.
View publication →Genetics in Medicine. 2016 Mar;44(1):48-53.
View publication →Proc Natl Acad Sci U S A. 2016 Feb;113(8):2170-2175.
View publication →J Cutan Pathol. 2015 Feb;42(2):108-117.
View publication →Transfus Apher Sci. 2014 Jun;50(3):379-387.
View publication →J Biol Chem. 2003 Jun 6;278(23):21295-21306.
View publication →Hematol Oncol Clin North Am. 2026 Feb;40(1):101-115.
View publication →Immunol Rev. 2026 Jan;337(1):e70088.
View publication →J Immunol. 2023 Nov 15;211(10):1450-1458. Corresponding author.
View publication →J Invest Dermatol. 2023 Feb;143(2):189-196. Corresponding author.
View publication →Frontiers in Pharmacology. 2019 Mar.
View publication →J Invest Dermatol. 2018 Sep;138(9):1906-1908. Corresponding author.
View publication →Oncogene. 2018 Mar;37(11):1409-1416. Corresponding author; featured in F1000Prime recommendations.
View publication →J Immunother Cancer. 2018 May;6(1):39.
View publication →Oncotarget. 2017 Aug 1;8(59):100863-100898.
View publication →Curr Rheumatol Rep. 2017 Jun;19(6):31. Corresponding author.
View publication →Melanoma Management. 2016 Sep;3(3):171-175.
View publication →Curr Treat Options Oncol. 2016 Jul;17(7):33. Corresponding author.
Citation onlyCurr Hematol Malig Rep. 2007 Oct;2(4):272-277.
View publication →J Am Acad Dermatol. 2026 Jun;94(6):e447-e448. doi: 10.1016/j.jaad.2026.01.094. Added from the UTSW Pure profile.
View publication →Bethesda, MD: AABB Press.
Citation onlyIn Wolverton eds., Comprehensive Drug Therapy, 3rd ed. China: Elsevier-Saunders.
Citation onlyBethesda, MD: AABB Press.
Citation onlyNew York, NY: American Geriatrics Society.
Citation onlyJAAD Case Reports. 2022 Mar;21:165-168. Corresponding author.
View publication →JAAD Case Reports. 2020 Nov 6;87-90.
View publication →PracticeUpdate website. Accessed Dec 4, 2020.
Citation onlyPracticeUpdate website. Accessed Dec 4, 2020.
Citation onlyJAAD Case Reports. 2019 Nov 13;5(12):1018-1026.
View publication →JAMA Dermatol. 2016 Apr;152(4):463-464. Corresponding author.
View publication →JAMA Dermatol. 2014 Aug 13. Corresponding author.
View publication →Int J Dermatol. 2011 Dec;50(12):1480-1485.
View publication →Yale J Biol Med. 2006 Dec;79(3-4):169-172.
View publication →